spacer
home > epc > autumn 2004 > logistics - what's in it for you?
PUBLICATIONS
European Pharmaceutical Contractor

Logistics - What's In It For You?

It is a common perception that logistics is simply a cost to be controlled, or a process to be improved. Whilst these are important considerations, the experience of really successful companies has shown the value of looking at logistics in a radically different way. Companies that grow quickly - and sustain that growth - use logistics as a competitive tool. How can you do this yourself? This article details some useful examples.

Get Your Logistics to Fit

You might imagine that the first time a company meets with a logistics consultant, the discussion would revolve around a logistics problem. In fact, most of the questions they will ask you aren't about your logistics at all, but about your business, customers, competition and your goals for the future.




Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

Banner of CRS on Samedan
spacer
By Stephen Errey, Managing Director at Lucidea Consulting Limited

Stephen Errey has been Managing Director of Lucidea Consulting Limited since 2001. He has worked in logistics for over 20 years, working with many blue-chip companies during that time, including AstraZeneca, Bristol Myers Squibb, Fresenius Kabi and Novartis. His experience covers Europe, the Middle East, America and Africa.

spacer
Stephen Errey
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

5th Annual Clinical Trial Supply West Coast

23-24 May 2012, Hyatt Regency San Francisco Airport, San Francisco

Arena International’s 5th Annual Clinical Trial Supply West Coast conference is the best platform to find solutions to minimize your clinical supply costs and tackle the biggest challenges of managing your clinical supply chain.
More info >>

 
News and Press Releases

GE Healthcare Life Sciences completes acquisition of Xcellerex, Inc.

GE Healthcare, the healthcare business of GE (NYSE: GE) announced today that it has completed the acquisition of Xcellerex, Inc., a supplier of innovative manufacturing technologies for the fast-growing biopharmaceutical industry. The acquisition expands GE Healthcare’s offering of technologies and services for the manufacture of biopharmaceuticals such as recombinant proteins, antibodies and vaccines, a key area of growth for the company.The strong strategic fit between the two companies, combined with expanded capabilities in product development and marketing, will offer significant customer benefits through complementary product and service offerings.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.